Tuberculose active sous biothérapies chez les patients atteints de spondyloarthrites : résultats du registre marocain des biothérapies (RBSMR) à 3 ans de suivi
S. Zemrani(Hôpital El Ayachi), B. Rachid(Hôpital El Ayachi), A. El Maghraoui, L. Ichchou(Hôpital El Ayachi), L. Achemlal, R. Niamane(Hôpital Militaire Avicenne), T. Harzy(Centre Hospitalier Universitaire Hassan II), I. Ghozlani(Régie Autonome Multi Services D'Agadir), Bouchra Amine(Hôpital El Ayachi), O. Mkinsi(Centre Hospitalier Universitaire Ibn Rochd), F. Allali(Délégation Paris 5), R. Aboukal(Direction de l’Epidémiologie et de Lutte contre les Maladies), I. El Bouchti, I. Elbinoune(Centre Hospitalier Ibn Sina), Ihsane Hmamouchi(International University of Rabat), S. Rostom(Mohammed V University), H. Hassikou, C. Charoui(Centre Hospitalier Ibn Sina)
Cited by 0
Related Papers
Why we should definitely include intra-articular hyaluronic acid as a therapeutic option in the management of knee osteoarthritis: Results of an extensive critical literature review
|Seminars in Arthritis and Rheumatism|2018|164
High Prevalence of Hypovitaminosis D in Morocco: Relationship to Lifestyle, Physical Performance, Bone Markers, and Bone Mineral Density
|Seminars in Arthritis and Rheumatism|2008|154
Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor α
|Annals of the Rheumatic Diseases|2003|122
Sarcopenia in rheumatoid arthritis: prevalence, influence of disease activity and associated factors
|Rheumatology International|2017|114